BioSpace
Research Roundup: COVID-19 Immunity, Stomach Acid Susceptibility and More
July 10, 2020
Investigators at LSU Health New Orleans Neuroscience Center of Excellence identified a new class of pipeline drugs to relieve pain and reduce fever. Furthermore, they appear to have decreased risk of addiction or damage to the liver or kidneys. In two models, the drugs, which are similar to acetaminophen, but do not appear to damage the liver or kidneys, decreased pain and reduced fever. The intellectual property has been licensed from LSU to the life science startup South Rampart Pharma, which is working to develop the drug in late preclinical development.